Literature DB >> 1761464

Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis.

D A Schwartz1, R A Helmers, C S Dayton, R K Merchant, G W Hunninghake.   

Abstract

To investigate factors that determine bronchoalveolar lavage (BAL) cellularity in patients with idiopathic pulmonary fibrosis (IPF), we compared BAL cells in patients with IPF (n = 83) to both nonsmoking (n = 111) and smoking (n = 19) normal volunteers. Patients with IPF had higher concentrations of BAL total cells and alveolar macrophages than nonsmoking volunteers and more BAL neutrophils and eosinophils than normal volunteers regardless of smoking status. Among patients with IPF, the numbers of alveolar macrophages, neutrophils, or eosinophils were strongly associated with either smoking status or pack-years of cigarette smoking. In fact, after accounting for cigarette smoking, using multivariate analysis, the only additional factors that were found to be associated with BAL cellularity were age (macrophages and eosinophils) and the percent predicted forced expired volume in 1 s (neutrophils). Additional multivariate models failed to identify a significant relationship between BAL cellularity and either the type of immunosuppressive therapy or other physiological measures of lung function. We conclude that cigarette smoking strongly influences BAL cellularity in patients with IPF. These findings suggest that cigarette smoking may have a role in the pathogenesis of IPF or may adversely affect the prognosis in patients with IPF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1761464     DOI: 10.1152/jappl.1991.71.5.1688

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

Review 1.  In search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many?

Authors:  M Turner-Warwick
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

2.  Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosis.

Authors:  Seiji Hayashi; Kin'ya Abe; Hiroto Matsuoka; Sho Goya; Hiroshi Morishita; Masahide Mori; Toru Arai; Hiroshi Kida; Kazumi Nishino; Yoshito Takeda; Tadashi Osaki; Isao Tachibana; Kentaro Kimura; Soichiro Yokota; Yoshikazu Inoue; Mitsunori Sakatani
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

3.  Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5).

Authors:  Dianne M Walters; Kevin M White; Ushma Patel; Martin J Davis; Roberta M Veluci-Marlow; Solomon Raju Bhupanapadu Sunkesula; James C Bonner; Jessica R Martin; Wes Gladwell; Steven R Kleeberger
Journal:  FASEB J       Date:  2013-11-27       Impact factor: 5.191

4.  Deletion of c-FLIP from CD11bhi Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis.

Authors:  Alexandra L McCubbrey; Lea Barthel; Michael P Mohning; Elizabeth F Redente; Kara J Mould; Stacey M Thomas; Sonia M Leach; Thomas Danhorn; Sophie L Gibbings; Claudia V Jakubzick; Peter M Henson; William J Janssen
Journal:  Am J Respir Cell Mol Biol       Date:  2018-01       Impact factor: 6.914

5.  The effect of eosinophils on collagen gel contraction and implications for tissue remodelling.

Authors:  U Zagai; C M Sköld; A Trulson; P Venge; J Lundahl
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 6.  The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Benjamin D Bringardner; Christopher P Baran; Timothy D Eubank; Clay B Marsh
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

7.  Early interstitial lung disease in familial pulmonary fibrosis.

Authors:  Ivan O Rosas; Ping Ren; Nilo A Avila; Catherine K Chow; Teri J Franks; William D Travis; J Philip McCoy; Rose M May; Hai-Ping Wu; Dao M Nguyen; Mauricio Arcos-Burgos; Sandra D MacDonald; Bernadette R Gochuico
Journal:  Am J Respir Crit Care Med       Date:  2007-07-19       Impact factor: 21.405

8.  Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis.

Authors:  C Agusti; A Xaubet; P Luburich; M C Ayuso; J Roca; R Rodriguez-Roisin
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

9.  Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history.

Authors:  Reza Karimi; Göran Tornling; Johan Grunewald; Anders Eklund; C Magnus Sköld
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.